F. J. Cleton

Medicine · Health Sciences

31h-index3.7kcitations81works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(8), Bone health and treatments(8), Immunotherapy and Immune Responses(7), Cancer Diagnosis and Treatment(7), Monoclonal and Polyclonal Antibodies Research(6)

Publications81 total

IRON ABSORPTION. IV. THE ABSORPTION OF HEMOGLOBIN IRON
Nutrition Reviews·2009· 24 cited
Wat zijn de huidige inzichten van therapie met tamoxifen bij jonge vrouwen met mammacarcinoom?
Bohn Stafleu van Loghum eBooks·2006
Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study
European Journal of Cancer·2004· 254 cited
Positron-emission tomography with [18F]fluorodeoxyglucose
Journal of Cancer Research and Clinical Oncology·2000· 171 citedOpen Access
Thromboembolic Events During Chemotherapy for Germ Cell Cancer: A Cohort Study and Review of the Literature
Journal of Clinical Oncology·2000· 222 cited
Vaccination of Melanoma Patients with an Allogeneic, Genetically Modified Interleukin 2-Producing Melanoma Cell Line
Human Gene Therapy·2000· 76 cited
[Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate].
PubMed·1999
Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients
Annals of Oncology·1998· 214 citedOpen Access
Free radicals and antioxidants in chemotherapyinduced toxicity
Cancer Treatment Reviews·1997· 323 cited
The diagnostic utility of somatostatin receptor scintigraphy in oncology
Journal of Cancer Research and Clinical Oncology·1996· 23 citedOpen Access
cis-Diamminedichloroplatinum (CDDP)-based chemotherapy (CT) induces a profound decrease in plasma levels of anti-oxidants (AO)
Mutation Research/Environmental Mutagenesis and Related Subjects·1996
Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?
European Journal of Cancer·1996· 60 cited
Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma
European Journal of Cancer·1995· 4 cited
Ifosfamide treatment as a 10-day continuous intravenous infusion
Journal of Cancer Research and Clinical Oncology·1995· 2 citedOpen Access
Ifosfamide treatment as a 10-day continuous intravenous infusion
Journal of Cancer Research and Clinical Oncology·1995· 28 citedOpen Access
Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer
Human Genetics·1995· 21 cited
Intraperitoneal therapy of ovarian cancer with retargeted lymphocytes by bispecific monoclonal antibodies and interleukin-2
European surgery. Supplement/European surgery·1995· 1 cited
Effect of Pregnancy on Prognosis for Young Women With Breast Cancer
Obstetrical & Gynecological Survey·1995· 18 cited
Hypercalcemia in patients with breast cancer: a survival study
Journal of Cancer Research and Clinical Oncology·1994· 32 citedOpen Access
Radioimmunotherapy: no news from the newcomer
Journal of Cancer Research and Clinical Oncology·1994· 10 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Susanne Osanto(7), Nir I. Weijl(6), H. G. Kwa(6), O. L. M. Bijvoet(5), D. Y. Wang(5), J.L. Hayward(5), J. Hermans(4), A.Th. van Holten-Verzantvoort(3), G.H. Blijham(3), H.P. Sleeboom(3), Adam Turnbull(3), Clement A. Finch(3), E.K.J. Pauwels(3), C.R. Franks(3), G. Stoter(3), E Engelsman(3), M. De Jong‐Bakker(3), J.-P. Persijn(3), R.D. Bulbrook(3), Eef G.W.M. Lentjes(2)